XML 105 R78.htm IDEA: XBRL DOCUMENT v3.25.1
Share-Based Compensation - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Jan. 01, 2024
Apr. 08, 2021
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2018
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Shares available for future grants (in shares)     7,285,275 6,207,664  
Number of shares reserved for issuance (in shares)     9,191,355    
Weighted-average grant date fair value (in usd per share)     $ 2.66 $ 1.99  
Aggregate intrinsic value of stock options exercised     $ 0.4 $ 0.2  
Unrecognized compensation cost related to options     $ 3.1 $ 3.0  
Stock options          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Weighted-average period over which unrecognized compensation cost is expected to be recognized     1 year 5 months 15 days 1 year 7 months 6 days  
Barinthus Biotherapeutics plc Share Award Plan 2021 | Restricted share units, options, share appreciation rights and restricted shares          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Shares available for issuance (in shares)   3,675,680      
Percentage of issued and outstanding ordinary shares available for issuance   4.00%      
Additional number of shares available for issuance (in shares) 1,544,282        
Expiration period   10 years      
Vesting period   3 years      
Shares available for future grants (in shares)     1,906,080 1,623,840  
Enterprise Management Incentive Share Option Scheme          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Vesting period         3 years
Expiration term         10 years
Enterprise Management Incentive Share Option Scheme | RSU's          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Number of shares reserved for issuance (in shares)         3,530,634